SBI Mutual Fund has increased its shareholding in Biocon to 7.0379% of the paid-up share capital. This increase results from the purchase of an additional 3,34,70,117 shares. The disclosure was made under Regulation 29(2) of SEBI’s Substantial Acquisition of Shares and Takeovers Regulations, 2011. The holding now totals 11,40,78,126 shares. The last disclosure was made on November 12, 2025, reporting a holding of 5.0013%.
Increased Shareholding by SBI Mutual Fund
SBI Mutual Fund has augmented its stake in Biocon, crossing the 7% threshold. The acquisition involved purchasing 3,34,70,117 shares. This purchase has elevated SBI Mutual Fund’s ownership to 11,40,78,126 shares, representing 7.0379% of Biocon’s paid-up share capital, effective as of January 16, 2026.
Details of the Transaction
The shares were acquired through open market transactions, including Qualified Institutional Placement and other market purchases and sales. This disclosure is pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The previous disclosure, dated November 12, 2025, reported a shareholding of 5.0013%.
Revised Holding Structure
Post-acquisition, the total equity share capital of Biocon stands at Rs. 8,10,45,38,865 consisting of 1,62,09,07,773 equity shares. The percentage of share capital has increased from 5.3445% to 7.0379% following SBI Mutual Fund’s additional investment.
Source: BSE
